Smartleaf Asset Management LLC Has $2.13 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Smartleaf Asset Management LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,032 shares of the medical equipment provider’s stock after acquiring an additional 673 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Intuitive Surgical were worth $2,125,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter valued at about $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 1.7 %

ISRG stock opened at $573.15 on Friday. The firm has a market cap of $204.14 billion, a price-to-earnings ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. The company’s fifty day simple moving average is $569.87 and its 200 day simple moving average is $529.06. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,077 shares of company stock valued at $4,620,025. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ISRG. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Truist Financial lifted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Finally, Royal Bank of Canada upped their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.